Fibrinolysis in Degos’ Disease

Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.

Thromb Haemost 1985; 54(03): 730
DOI: 10.1055/s-0038-1660113

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

J A Páramo

¹Service of Hematology, University Clinic of Navarra, Spain
E Rocha

¹Service of Hematology, University Clinic of Navarra, Spain
B Cuesta

¹Service of Hematology, University Clinic of Navarra, Spain
J M Arejola

²Dept. of Internal Medicine, University Clinic of Navarra, Spain
M Montejo

³Hospital Cruces de Bilbao, Spain
J Aguirre

³Hospital Cruces de Bilbao, Spain
J Prieto

²Dept. of Internal Medicine, University Clinic of Navarra, Spain
E Rocha Hernando Dr.

Service of Hematology, University Clinic of Navarra, Avda. Pío XII s/n Apartado 192, 318080-Pamplona, Spain

Received 03. Juni 1985

Accepted 29. Juli 1985

Publikationsdatum:
19. Juli 2018 (online)

References
1 Black MM, Nishioka K, Levene GM. The role of dermal blood vessels in the pathogenesis of malignant atrophic papulosis (Degos’ disease). A study of two cases using enzyme histochemical, fibrinolytic, electron-microscopal and immunological techniques. Br J Dermatol 1973; 88: 213-219

Reference Link Ris
Crossref PubMed Suche in Google Scholar
2 Colucci M, Paramo JA, Collen D. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest 1985; 75: 818-824

Reference Link Ris
Crossref PubMed Suche in Google Scholar
3 Delaney TJ, Black MM. Effect of fibrinolytic treatment in malignant atrophic papulosis. Br Med J 1975; 3: 415

Reference Link Ris
PubMed Suche in Google Scholar
4 Chmielewska J, Ranby M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983; 31: 427-436

Reference Link Ris
Crossref PubMed Suche in Google Scholar